Description
Ingredients | Aesculus Hippocastanum Extract, Tyrosine, L-carnitine, Sodium Chloride, Juglans Regia (Walnut) Seed Extract, Thermus thermophilus g |
Application part | Body, face |
Packing unit | 10ml x 5 vials |
Country of origin | Republic of Korea |
The new, effective lipolytic complex Super V-LINE Sol. is perfect for correcting body fat. The use of this indirect injection lipolytic for the face has proven effective. Indirect lipolytic, for the beginning, are known to be safer than direct lipolytic complexes.
Super V-LINE Sol expedites lymph circulation & melting excess fat in the face and reducing swelling. It will let you see the effect of skin regeneration.
Super V-LINE Sol Advantages:
- Good tolerability of this drug is also noted. It does not cause adverse reactions in the body, as it contains natural components.
- Removes excess fat while tightening the skin.
- Accelerates the processes of cell regeneration and renewal.
- Provides a long-lasting correction result.
- Show immediate treatment effect of fat removal with perfect results.
If subcutaneous tissue in the oval of the face and the chin area is decent, then you can pierce up to 10 ml of the drug (1 bottle), from 0.5 to 1.0 ml per injection, tunnel retrograde. Quick and straightforward treatment in 5-10 minutes and the results can be shown with only 1-time treatment.
Application area of Super V-LINE Sol:
- Cheeks, zygomatic region
- Sagging skin on the cheeks
- Lower ear zone
- Double chin
- Face skin lifting
- The area around the eyes
Super V-LINE Sol expedites lymph circulation & melting excess fat in the face and reducing swelling. It will let you see the effect of skin regeneration.
It can also be used for sagging parts which are produced with age.
Remove the fat by giving the effect of face lifting on cheeks and double chin. It makes a perfect face line with the V curve.
Product for professional use only.
By purchasing, you declare you are a doctor or cosmetologist trained in aesthetic medicine.super v line
Reviews
There are no reviews yet.